|
Headlines
Market news and breaking stories live from Dow Jones Newswires
Market Commentary
A technical analysis commentary of the major markets, only from INO
Smart Scan
A premium service, alerting you to changes in the market by web and email.
Extreme Futures / Stocks
Extreme Markets from all exchanges, updated throughout the trading day.
|
| |
|
Trade Triangle Technology, Advanced Charts, SmartScan, Trading Workshops.
The premier online video learning platform for traders.
Daily Portfolio Scan and Analysis
|
| |
|
UPDATE: Hungary To Buy 6M Swine Flu Omninvest Vaccine Doses188 days ago
(Adds further details about price, drug.)
BUDAPEST (Dow Jones)--Hungary will buy six million doses of the vaccine for the A/H1N1, or swine flu, virus being developed and manufactured by Hungarian vaccine maker Omninvest Kft., Health Minister Tamas Szekely said Wednesday.
Preclinical tests of the vaccine have been concluded and the clinical trials will likely start soon, he said.
Hungary plans no purchases of swine flu vaccine from other manufacturers, Szekely added. The 6 million dosages will cover about 60% of Hungary's population of about 10 million, will cost 6 billion forints ($32.5 million), the minister said at a press conference. That will be more than the 40% coverage the World Health Organization recommends, he said.
At present, the government has enough stocks of antiviral drugs to treat swine flu to cover 7.5% to 8.5% of the Hungarian population, Szekely said.
Szekely said Omninvest's swine flu vaccine was chosen as it is administered in one shot, compared with other vaccines being developed by other companies, which require two shots.
The minister added that it also costs 25% of comparable products under development and will be available in mid-October - much sooner than the February 2010 date that other swine flu vaccines are expected to become available.
Omninvest's vaccine will cost 1,100 forints ($5.92) a dosage as against EUR16-18 a shot its possible alternatives are expected to cost, Szekely said.
Children between six months and three years of age will receive the vaccine free of charge as will pregnant women, those older than 60, and those younger than 60 with a chronic illness.
Of the 6 million dosages, two million will be sold through pharmacies and 500,000 will be used to vaccinate health care and utilities workers, and employees at companies of strategic importance, Szekely said.
Omninvest has been manufacturing vaccines against seasonal flu for Hungary's state healthcare system for the past 15 years.
It has already manufactured and shipped its vaccine for this year, Szekely added.
Company Web site: www.omninvest.hu
-By Margit Feher, Dow Jones Newswires; +361-267-0622; margit.feher@dowjones.com
Click here to go to Dow Jones NewsPlus, a web front page of today's most important business and market news, analysis and commentary: http://www.djnewsplus.com/access/al?rnd=py6XKysBWxRFQBX8LswcYA%3D%3D. You can use this link on the day this article is published and the following day.
(END) Dow Jones Newswires
August 05, 2009 12:35 ET (16:35 GMT)
< Back to News Index
|
